P

Pulike Biological Engineering Inc
SSE:603566

Watchlist Manager
Pulike Biological Engineering Inc
SSE:603566
Watchlist
Price: 13.19 CNY -3.01% Market Closed
Market Cap: 4.5B CNY
Have any thoughts about
Pulike Biological Engineering Inc?
Write Note

Pulike Biological Engineering Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pulike Biological Engineering Inc
Gross Profit Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
P
Pulike Biological Engineering Inc
SSE:603566
Gross Profit
ÂĄ674.4m
CAGR 3-Years
-1%
CAGR 5-Years
10%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Gross Profit
ÂĄ9.1B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Gross Profit
ÂĄ4.8B
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
21%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Gross Profit
ÂĄ21.4B
CAGR 3-Years
-6%
CAGR 5-Years
5%
CAGR 10-Years
15%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Gross Profit
ÂĄ10.5B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
8%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Gross Profit
ÂĄ319.6m
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pulike Biological Engineering Inc's Gross Profit?
Gross Profit
674.4m CNY

Based on the financial report for Jun 30, 2024, Pulike Biological Engineering Inc's Gross Profit amounts to 674.4m CNY.

What is Pulike Biological Engineering Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
10%

Over the last year, the Gross Profit growth was -17%. The average annual Gross Profit growth rates for Pulike Biological Engineering Inc have been -1% over the past three years , 10% over the past five years .

Back to Top